Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer()

Pancreatic ductal adenocarcinoma (PDAC) is a deadly disease with an overall median 5-year survival rate of 8%. This poor prognosis is because of the development of resistance to chemotherapy and radiation therapy and lack of effective targeted therapies. IκB kinase enhancer (IKBKE) overexpression wa...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transl Oncol
Asıl Yazarlar: Challa, Sridevi, Husain, Kazim, Kim, Richard, Coppola, Domenico, Batra, Surinder K., Cheng, Jin Q., Malafa, Mokenge P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Neoplasia Press 2020
Konular:
Original article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6994835/
https://ncbi.nlm.nih.gov/pubmed/32004866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tranon.2019.11.009
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller